BDSX Q1 2023 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q1 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$9M+38.3% YoY

Gross Profit

$6M65.0% margin

Operating Income

-$16M-180.8% margin

Net Income

-$19M-206.5% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-5.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$81M

Total Liabilities

$76M

Stockholders' Equity

$5M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$7M	+38.3%
Gross Profit	$6M	$3M	+77.7%
Operating Income	-$16M	-$14M	-13.2%
Net Income	-$19M	-$16M	-20.0%

Revenue Segments

Diagnostic Tests

$9M95%

Service

$411,0005%